ATE511652T1 - Verfahren zur bestimmung der antikörper-igg- avidität - Google Patents

Verfahren zur bestimmung der antikörper-igg- avidität

Info

Publication number
ATE511652T1
ATE511652T1 AT06836818T AT06836818T ATE511652T1 AT E511652 T1 ATE511652 T1 AT E511652T1 AT 06836818 T AT06836818 T AT 06836818T AT 06836818 T AT06836818 T AT 06836818T AT E511652 T1 ATE511652 T1 AT E511652T1
Authority
AT
Austria
Prior art keywords
igg avidity
antibodies igg
determining antibodies
determining
avidity
Prior art date
Application number
AT06836818T
Other languages
English (en)
Inventor
Gregory T Maine
Stephen C Hsu
Darwin D Smith Jr
Dominick L Pucci
Joerg Herzogenrath
Ingo Curdt
Heike Maria Christ
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE511652T1 publication Critical patent/ATE511652T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • G01N2333/45—Toxoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT06836818T 2005-11-02 2006-11-02 Verfahren zur bestimmung der antikörper-igg- avidität ATE511652T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/265,481 US7432046B2 (en) 2005-11-02 2005-11-02 Methods for the determination of antibody IgG avidity
PCT/US2006/042818 WO2007056064A1 (en) 2005-11-02 2006-11-02 Methods for the determination of antibody igg avidity

Publications (1)

Publication Number Publication Date
ATE511652T1 true ATE511652T1 (de) 2011-06-15

Family

ID=37772854

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06836818T ATE511652T1 (de) 2005-11-02 2006-11-02 Verfahren zur bestimmung der antikörper-igg- avidität

Country Status (7)

Country Link
US (1) US7432046B2 (de)
EP (1) EP1943519B1 (de)
JP (1) JP4966313B2 (de)
AT (1) ATE511652T1 (de)
CA (1) CA2628399C (de)
ES (1) ES2366050T3 (de)
WO (1) WO2007056064A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107102135A (zh) * 2011-05-20 2017-08-29 阿波特日本有限公司 用于减少非特异性结合的免疫检验方法和试剂
CN104634976B (zh) * 2015-01-13 2017-04-19 必欧瀚生物技术（合肥）有限公司 一种人巨细胞病毒活动性感染快速检测方法及用于该检测方法的试剂盒
US20180271998A1 (en) 2015-12-04 2018-09-27 Merrimack Pharmaceuticals, Inc. Disulfide-stabilized fabs
GB2565954B (en) * 2016-06-10 2022-09-07 Hitachi High Tech Corp Method and apparatus for analyzing biomolecules
US11371980B2 (en) 2016-10-20 2022-06-28 Hitachi High-Tech Corporation Method for treating biomolecules and method for analyzing biomolecules

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3940598A1 (de) 1989-12-08 1991-06-13 Behringwerke Ag Toxoplasma gondii-antigene, ihre herstellung und ihre verwendung
IT1266740B1 (it) 1994-07-01 1997-01-14 Maria Paola Landini Materiale proteico ricombinante legante anticorpi contro il citomegalovirus umano, reagenti diagnostici derivati da tale
US5705330A (en) 1995-04-14 1998-01-06 Abbott Laboratories Chemiluminescent immunoassay for antibody detection
DE19548375A1 (de) * 1995-12-27 1997-07-03 Behringwerke Ag Immunologische Bestimmungsmethode
DE19718361A1 (de) 1997-05-02 1998-11-05 Dade Behring Marburg Gmbh Immunoassay zur Aviditätsbestimmung von Immunglobulinen
JP3831754B2 (ja) * 1997-10-23 2006-10-11 青才 文江 トキソプラズマ・ゴンディ抗原、これをコードする核酸並びに該抗原に対する抗体
US6329157B1 (en) * 1998-05-28 2001-12-11 Abbott Laboratories Antigen cocktails and uses thereof
US7094879B2 (en) 2002-10-02 2006-08-22 Abbott Laboratories Genetically engineered P30 antigen, improved antigen cocktail, and uses thereof

Also Published As

Publication number Publication date
EP1943519B1 (de) 2011-06-01
JP4966313B2 (ja) 2012-07-04
CA2628399C (en) 2014-02-25
US7432046B2 (en) 2008-10-07
CA2628399A1 (en) 2007-05-18
WO2007056064A1 (en) 2007-05-18
ES2366050T3 (es) 2011-10-14
US20070099295A1 (en) 2007-05-03
JP2009515169A (ja) 2009-04-09
EP1943519A1 (de) 2008-07-16

Similar Documents

Publication Publication Date Title
CY2018013I2 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
HRP20151252T4 (hr) Modificirani fab ulomci protutijela
EP1799260A4 (de) Antiamyloide antikörper, zusammensetzungen, verfahren und verwendungen
IS8266A (is) Breytt mennsk IGF-1R mótefni
IL192129A0 (en) Anti-mn antibodies and methods of using same
CY1110337T1 (el) Παρασκευη πρεγκαμπαλινης και σχετικων ενωσεων
IL190472A (en) Glyphican Antibody 3 Methods for their preparation and use
FR15C0048I1 (fr) Anticorps antagonistes de il-17
IL191600A (en) A specific neutralizing antibody against il-6 from a person and various aspects related to it
EP1616881A4 (de) Anti-mpl-antikörper
DE602004032160D1 (de) Verfahren zur Zubereitung von Getränken
EP1868647A4 (de) Ov064-bindende antikörper und verfahren zu ihrer verwendung
WO2006026759A3 (en) Humanized anti-beta7 antagonists and uses therefor
WO2009155324A3 (en) Pigf-1 assay and kits and components thereof
IL175985A0 (en) Methods and compositions for the production of monoclonal antibodies
EP2084185A4 (de) Menschliche antikörper zur neutralisierung des menschlichen metapneumovirus
WO2007001264A3 (en) Method of making recombinant human antibodies for use in biosensor technology
EP1992282A4 (de) Verfahren zur nicht-invasiven bestimmung einer endothelfunktion und vorrichtung zur durchführung dieses verfahrens
DE112005001904A5 (de) Verfahren zur Bestimmung relevanter Objekte
ATE517340T1 (de) Sätze gegen kurze epitope gerichteter digitaler antikörper sowie diese verwendende verfahren
EP2185718A4 (de) Menschliche monoklonale antikörper und verfahren zu ihrer herstellung
ATE546524T1 (de) Verfahren zur herstellung aktiver scfv-antikörper und bibliotheken dafür
ATE336597T1 (de) Verfahren zur gewinnung von gold
EP1643894A4 (de) Verfahren, kits und antikörper zum nachweis von parathyroid
EP1598368A4 (de) Anti-pci-neutralisierungs-antikörper

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties